Suppr超能文献

吡嗪酰胺曼尼希碱的合成及其抗结核特性。

Synthesis of pyrazinamide Mannich bases and its antitubercular properties.

作者信息

Sriram Dharmarajan, Yogeeswari Perumal, Reddy Sushma Pobba

机构信息

Medicinal Chemistry Research Laboratory, Pharmacy group, Birla Institute of Technology and Science, Pilani 333031, India.

出版信息

Bioorg Med Chem Lett. 2006 Apr 15;16(8):2113-6. doi: 10.1016/j.bmcl.2006.01.064. Epub 2006 Feb 7.

Abstract

A series of pyrazinamide (PAZ) Mannich bases has been synthesized by reacting PAZ, formaldehyde, and various substituted piperazines using microwave irradiation with the yield ranging from 46% to 86%. The synthesized compounds were evaluated for antimycobacterial activity in vitro and in vivo against Mycobacterium tuberculosis H37Rv (MTB). Among the synthesized compounds, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-4-((pyrazine-2-carboxamido)methyl)piperazin-1-yl)-4-oxoquinoline-3-carboxylic acid (17) was found to be the most active compound in vitro with MIC of 0.39 and 0.2 microg/mL against MTB and multidrug-resistant MTB, respectively. In the in vivo animal model 17 decreased the bacterial load in lung and spleen tissues with 1.86 and 1.66-log10 protections, respectively.

摘要

通过微波辐射使吡嗪酰胺(PAZ)、甲醛与各种取代哌嗪反应,合成了一系列吡嗪酰胺(PAZ)曼尼希碱,产率在46%至86%之间。对合成的化合物进行了体外和体内抗结核分枝杆菌活性评估,以对抗结核分枝杆菌H37Rv(MTB)。在合成的化合物中,发现1-环丙基-6-氟-1,4-二氢-8-甲氧基-7-(3-甲基-4-((吡嗪-2-甲酰胺基)甲基)哌嗪-1-基)-4-氧代喹啉-3-羧酸(17)是体外活性最强的化合物,对MTB和耐多药MTB的最低抑菌浓度分别为0.39和0.2微克/毫升。在体内动物模型中,化合物17分别使肺和脾组织中的细菌载量降低了1.86和1.66个对数10级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验